Sio Capital Gains An Impressive 23.3% In 2018 As Biotech Shorts Pay Off: Here Are The Companies That They Are Betting AgainstRupert Hargreaves
Sio Capital Management, the healthcare-focused long/short equity hedge fund achieved an outstanding outperformance for its partners in 2018.
According to a copy of the firm's full-year letter, which has been reviewed by ValueWalk, Sio returned 23.3% net in 2018. These returns compare with returns of -4.4% for the S&P 500 Total Return Index, 1.0% for the MSCI World Healthcare Index, and -10.4% for the MSCI World Index.
If you’re looking for value stocks, and exclusive access to value-focused hedge fund managers, check out ValueWalk’s exclusive value newsletter, Hidden Value Stocks. Use code 15percent10 at checkout. Offer valid for next 10 subscribers or March 31, 2019 whichever comes first!
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible